{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:31:04Z","timestamp":1761561064642},"reference-count":11,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,6,14]],"date-time":"2006-06-14T00:00:00Z","timestamp":1150243200000},"content-version":"vor","delay-in-days":3451,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pacing Clinical Electrophis"],"published-print":{"date-parts":[[1997,1]]},"abstract":"<jats:p>The purpose of this study was to determine the termination and acceleration rates for 1 to 6 attempts of antitachycardia pacing (ATP) delivered by ICD in order to terminate spontaneously occurring VTs. Twenty\u2010four ICD recipients with active ATP programs, including a maximum of six ATP sequences and spontaneously occurring VTs during follow\u2010up, were investigated. During a mean follow\u2010up of 42 \u00b1 15 months (range, 17\u201363 months) 413 spontaneous VT episodes (17 \u00b1 14; range, 1\u201349 per patient) resulting in appropriate ATP delivery by the ICD occurred. ATP successfully terminated 328 episodes (80 %) with a mean number of 1.6 \u00b1 1.1 pacing sequences. Eighty episodes (19%) were accelerated by ATP and 5 (1%) were unresponsive to ATP. The ATP success decreased until the third ATP sequence (59%\u2192 31%\u2192 24%), but increased again in the fourth to sixth attempt (46%\u2192 46%\u2192 29%). The acceleration rate increased from sequence one to sequence three (8%\u2192 13%\u2192 28%), but decreased significantly in further ATP attempts (19%\u2192 0%\u2192 0%). The mean time delays until redetection or termination after 4, 5, and 6 attempts of ATP were 22 \u00b1 5 seconds, 37 \u00b1 2 seconds, and 41 \u00b1 9 seconds, respectively. Nine patients (37%) used \u22653 ATP attempts during follow\u2010up and all of them had a therapeutic benefit from it. Five out of 13 VTs (38%) treated with \u22654 attempts could ultimately be terminated by ATP. The results of this study demonstrate that the first ATP sequence is the most effective and that &gt; 4 ATP attempts may be useful in a minority of patients. There seems to be a low risk of VT acceleration by the fourth to sixth ATP sequence. Because of the associated time delay, a high number of ATP attempts should only be programmed in patients with hemodynamically well\u2010tolerated stable VTs.<\/jats:p>","DOI":"10.1111\/j.1540-8159.1997.tb04842.x","type":"journal-article","created":{"date-parts":[[2006,6,14]],"date-time":"2006-06-14T10:08:02Z","timestamp":1150279682000},"page":"198-202","source":"Crossref","is-referenced-by-count":19,"title":["<b>Antitachycardia Pacing in Patients with Implantable Cardioverter Defibrillators:<\/b> How Many Attempts Are Useful?"],"prefix":"10.1111","volume":"20","author":[{"given":"ROLAND","family":"FRIES","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ARMIN","family":"HEISEL","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GERHARD","family":"KALWEIT","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JENS","family":"JUNG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HERMANN","family":"SCHIEFFER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,6,14]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8159.1995.tb02569.x"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(94)90084-1"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8159.1993.tb01556.x"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(93)90343-Y"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.86.2.363"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8159.1993.tb01531.x"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(93)90984-K"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8159.1993.tb01037.x"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(93)90318-U"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8159.1995.tb02469.x"},{"key":"e_1_2_1_12_2","first-page":"35","article-title":"Die Bedeutung der antitachykarden Stimulation bei Patienten mit Defibrillatoren der 3. Generation","volume":"84","author":"Trappe HJ","year":"1995","journal-title":"Z Kardiol"}],"container-title":["Pacing and Clinical Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1540-8159.1997.tb04842.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1540-8159.1997.tb04842.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T16:22:34Z","timestamp":1698423754000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1540-8159.1997.tb04842.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,1]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1997,1]]}},"alternative-id":["10.1111\/j.1540-8159.1997.tb04842.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1540-8159.1997.tb04842.x","archive":["Portico"],"relation":{},"ISSN":["0147-8389","1540-8159"],"issn-type":[{"value":"0147-8389","type":"print"},{"value":"1540-8159","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,1]]}}}